Target intelligence / Profile preview

RNA, U4 small nuclear 85, pseudogene (RNU4-85P)

Target
RNU4-85P
Molecular classification
Other (Pseudogene), Noncoding RNA, Small nuclear RNA pseudogene
01

Overview

RNU4-85P is a human pseudogene with sequence homology to the U4 small nuclear RNA involved in mRNA splicing. Unlike functional U4 snRNAs, it does not produce an active RNA or protein product and has no known biological or disease roles. It likely arose through retrotransposition and is considered biologically inert[1][3].

Other names
RNU4-85PRNA, U4 small nuclear 85, pseudogeneU4 snRNA pseudogene

Beyond the preview

Go deeper on RNA, U4 small nuclear 85, pseudogene (RNU4-85P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U4 small nuclear 85, pseudogene (RNU4-85P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call